After the invasion of the smoking cranks last week into the comments of the three posts I somehow ended up doing on the topic of secondhand smoke (SHS), the health dangers it poses, and some of the deceptive quote mining used in the service of trying to discredit studies demonstrating a moderate but real risk […]
Category: Clinical trials
It sure took the FDA long enough, nearly five months, but it finally acted. It finally shut Jim Tassano down, as this notice on TheDCASite.com states: Two agents from the FDA visited us on Tuesday,July 17, 2007 and ordered that we stop making and selling DCA. Unfortunately, the site www.buydca.com will be shut down immediately. […]
Share this:
Little did I know when I posted my first article on the evidence supporting health hazards due to secondhand smoke that it would end up dominating the comments of this blog for three full days and lead me to a site that’s so full of pseudoscience, logical fallacies, and just plain B.S. that it is […]
Share this:
Not surprisingly, in response to my article on the health risks of secondhand smoke yesterday, the “skeptics’ came out in force, although I must admit that even I hadn’t expected quite as large an influx as what appeared. Perhaps I’ll prepare a general response in the near future (and, no, I didn’t take the Surgeon […]
Share this:
It looks as though I’ve been tagged by Drug Monkey, who apparently thinks that I might have something worth saying about the state of the NIH and its peer review system, about which the NIH is presently soliciting comments, as pointed out to me by Medical Writing, Editing, & Grantsmanship. Why Drugmonkey might think this […]
